We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAY
601
DELISTED
Bottomline Technologies Inc
EPAY
$89.6M 0.02%
4,159,437
-1,030,563
-20% -$27M
D icon
602
Dominion Energy
D
$59.8B
$89.5M 0.02%
1,148,575
+53,300
+5% +$3.87M
RDN icon
603
Radian Group
RDN
$4.87B
$89.4M 0.02%
8,579,970
+20,402
+0.2% +$240K
F icon
604
Ford
F
$55.1B
$89.4M 0.02%
7,108,626
+69,290
+1% +$913K
ETN icon
605
Eaton
ETN
$179B
$89.4M 0.02%
1,495,941
-1,932,105
-56% -$119M
PSX icon
606
Phillips 66
PSX
$90B
$89.2M 0.02%
1,124,581
-10,589
-0.9% -$865K
ZWS icon
607
Zurn Elkay Water Solutions
ZWS
$8.46B
$89.1M 0.02%
9,423,242
-9,364,734
-50% -$94.2M
APC
608
DELISTED
Anadarko Petroleum
APC
$88.7M 0.02%
1,664,789
-1,563,091
-48% -$79.2M
EAT icon
609
Brinker International
EAT
$10.5B
$88.5M 0.02%
1,943,420
+154,870
+9% +$7.07M
HASI icon
610
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
$87.9M 0.02%
4,069,362
+454,020
+13% +$9.12M
LABL
611
DELISTED
Multi-Color Corp
LABL
$87.6M 0.02%
1,380,986
-149,810
-10% -$8.86M
LFUS icon
612
Littelfuse
LFUS
$11.7B
$87.5M 0.02%
740,080
-2,530
-0.3% -$294K
TOWN icon
613
Towne Bank
TOWN
$3.49B
$87.2M 0.02%
4,027,801
+1,376,610
+52% +$28.8M
ALV icon
614
Autoliv
ALV
$8.85B
$86.9M 0.02%
1,133,725
+235,316
+26% +$20.2M
BFS
615
Saul Centers
BFS
$850M
$86.7M 0.02%
1,405,170
-9,980
-0.7% -$556K
FTI icon
616
TechnipFMC
FTI
$29.5B
$86.5M 0.02%
4,358,189
+579,555
+15% +$12M
AVNT icon
617
Avient
AVNT
$4.16B
$86.3M 0.02%
2,450,175
-152,920
-6% -$5.39M
SSTK icon
618
Shutterstock
SSTK
$208M
$86.3M 0.02%
1,885,029
-1,539,880
-45% -$63.6M
ADTN icon
619
Adtran
ADTN
$665M
$85.1M 0.02%
4,562,271
-1,964,627
-30% -$37.4M
TGI
620
DELISTED
Triumph Group
TGI
$85.1M 0.02%
2,396,767
+596,636
+33% +$21.6M
CAT icon
621
Caterpillar
CAT
$393B
$85.1M 0.02%
1,121,992
+19,966
+2% +$1.5M
BLMN icon
622
Bloomin' Brands
BLMN
$975M
$85M 0.02%
4,756,726
+84,080
+2% +$1.56M
STFC
623
DELISTED
State Auto Financial Corp
STFC
$85M 0.02%
3,878,680
+54,030
+1% +$1.13M
CDP icon
624
COPT Defense Properties
CDP
$4.19B
$84.8M 0.02%
2,867,745
-1,133,280
-28% -$30.5M
RAI
625
DELISTED
Reynolds American Inc
RAI
$83.7M 0.02%
1,552,326
+5,440
+0.4% +$273K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.